Literature DB >> 30177020

Role of Mesangial-Podocytic-Tubular Cross-Talk in IgA Nephropathy.

Joseph C K Leung1, Kar Neng Lai2, Sydney C W Tang3.   

Abstract

IgA nephropathy (IgAN), a common primary glomerulonephritis worldwide, is associated with a substantial risk of progression to end-stage renal failure. The disease runs a highly variable clinical course with frequent involvement of tubulointerstitial damage. A subgroup of IgAN with proximal tubular epithelial cells (PTECs) and tubulointerstitial damage often is associated with rapid progression to end-stage renal failure. Human mesangial cell-derived mediators lead to podocyte and tubulointerstitial injury via mesangial-podocytic-tubular cross-talk. Although mesangial-podocytic communication plays a pathogenic role in podocytic injury, the implication of a podocyte-PTEC cross-talk pathway in the progression of tubulointerstitial injury in IgAN should not be underscored. We review the role of mesangial-podocytic-tubular cross-talk in the progression of IgAN. We discuss how podocytopathy in IgAN promotes subsequent PTEC dysfunction and whether tubulointerstitial injury affects the propagation of podocytic injury in IgAN. A thorough understanding of the cross-talk mechanisms among mesangial cells, podocytes, and PTECs may lead to better design of potential therapeutic options for IgAN.
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  IgAN; cross-talk; mesangial cell; podocyte; tubular

Mesh:

Year:  2018        PMID: 30177020     DOI: 10.1016/j.semnephrol.2018.05.018

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  10 in total

1.  TNF-α-mediated podocyte injury via the apoptotic death receptor pathway in a mouse model of IgA nephropathy.

Authors:  Qiang Wan; Jiabao Zhou; Yansheng Wu; Liqiang Shi; Weiwei Liu; Jiaoying Ou; Jiandong Gao
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

2.  Budesonide versus systemic corticosteroids in IgA Nephropathy: A retrospective, propensity-matched comparison.

Authors:  Gener Ismail; Bogdan Obrişcă; Roxana Jurubiţă; Andreea Andronesi; Bogdan Sorohan; Alexandra Vornicu; Ioanel Sinescu; Mihai Hârza
Journal:  Medicine (Baltimore)       Date:  2020-06-26       Impact factor: 1.889

3.  Autosomal Dominant Tubulointerstitial Kidney Disease-Uromodulin Misclassified as Focal Segmental Glomerulosclerosis or Hereditary Glomerular Disease.

Authors:  Justin Chun; Minxian Wang; Maris S Wilkins; Andrea U Knob; Ava Benjamin; Lihong Bu; Martin R Pollak
Journal:  Kidney Int Rep       Date:  2020-01-08

4.  The Study of Angptl4-Modulated Podocyte Injury in IgA Nephropathy.

Authors:  Sha Jia; Xiaofeng Peng; Ludan Liang; Ying Zhang; Meng Li; Qin Zhou; Xiujin Shen; Yucheng Wang; Cuili Wang; Shi Feng; Jianghua Chen; Pingping Ren; Hong Jiang
Journal:  Front Physiol       Date:  2021-02-11       Impact factor: 4.566

5.  Spleen Tyrosine Kinase Inhibition Ameliorates Tubular Inflammation in IgA Nephropathy.

Authors:  Wai Han Yiu; Kam Wa Chan; Loretta Y Y Chan; Joseph C K Leung; Kar Neng Lai; Sydney C W Tang
Journal:  Front Physiol       Date:  2021-03-15       Impact factor: 4.566

6.  Urine β2-Microglobulin and Retinol-Binding Protein and Renal Disease Progression in IgA Nephropathy.

Authors:  Xiaoqi Shen; Jun Cheng; Guizhen Yu; Xiayu Li; Heng Li; Jianghua Chen
Journal:  Front Med (Lausanne)       Date:  2021-12-22

7.  Intrarenal Single-Cell Sequencing of Hepatitis B Virus Associated Membranous Nephropathy.

Authors:  Leilin Yu; Wei Lin; Chanjuan Shen; Ting Meng; Peng Jin; Xiang Ding; Peter J Eggenhuizen; Joshua D Ooi; Rong Tang; Wannian Nie; Xia Li; Xiangcheng Xiao; Yong Zhong
Journal:  Front Med (Lausanne)       Date:  2022-07-22

8.  Liuwei Dihuang Pills Inhibit Podocyte Injury and Alleviate IgA Nephropathy by Directly Altering Mesangial Cell-Derived Exosome Function and Secretion.

Authors:  Xiaodong Zhu; Xiaogang Shen; Bo Lin; Jiaxi Fang; Juan Jin; Qiang He
Journal:  Front Pharmacol       Date:  2022-07-11       Impact factor: 5.988

Review 9.  Has The Time Arrived to Refine The Indications of Immunosuppressive Therapy and Prognosis in IgA Nephropathy?

Authors:  Bogdan Obrișcă; Ioanel Sinescu; Gener Ismail; Gabriel Mircescu
Journal:  J Clin Med       Date:  2019-10-02       Impact factor: 4.241

10.  Proteomic signature of tubulointerstitial tissue predicts prognosis in IgAN.

Authors:  Flavia Teodora Ioana Paunas; Kenneth Finne; Sabine Leh; Hans-Peter Marti; Frode Berven; Bjørn Egil Vikse
Journal:  BMC Nephrol       Date:  2022-03-24       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.